You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Express Scripts

Last Updated: September 20, 2020

DrugPatentWatch Database Preview


➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Potassium Iodide patents expire, and when can generic versions of Potassium Iodide launch?

Potassium Iodide is a drug marketed by Mission Pharmacal Co and Roxane and is included in two NDAs.

The generic ingredient in POTASSIUM IODIDE is potassium iodide. There are two hundred and forty drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the potassium iodide profile page.

US ANDA Litigation and Generic Entry Outlook for Potassium Iodide

A generic version of POTASSIUM IODIDE was approved as potassium iodide by MISSION PHARMACAL CO on March 24th, 2016.

  Start Trial

Drug patent expirations by year for POTASSIUM IODIDE

See drug prices for POTASSIUM IODIDE

Recent Clinical Trials for POTASSIUM IODIDE

Identify potential brand extensions & 505(b)(2) entrants

Cairo UniversityPhase 4
Alexandria UniversityPhase 2/Phase 3
Nourhan M.AlyPhase 2/Phase 3

See all POTASSIUM IODIDE clinical trials

US Patents and Regulatory Information for POTASSIUM IODIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mission Pharmacal Co POTASSIUM IODIDE potassium iodide SOLUTION;ORAL 206211-001 Mar 24, 2016 OTC No No   Start Trial   Start Trial   Start Trial
Roxane POTASSIUM IODIDE potassium iodide SOLUTION;ORAL 018551-001 Feb 19, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.